Basic Info
  • Factory Location: Lianyungang, Jiangsu, China

    Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

  • Sample Provided: no

    Tacrolimus is an immunosuppressive drug used mainly after allogeneic organ transplant to lower the risk of organrejection. It achieves this by inhibiting the production of interleukin-2, a molecule that promotes the development and proliferation of T cells, which are vital to the body's learned (or adaptive) immune response. Tacrolimus is also used in the treatment of other T cell-mediated diseases such aseczema (for which it is applied to the skin in a medicated ointment), severe refractory uveitis afterbone marrow transplants, exacerbations of minimal change disease, Kimura's disease, and the skin condition vitiligo.
    Strength: 0.5mg; 1mg; 5mg.
    This product is still in R&D stage.

    US-ANDA in preparation.

Send your message to this supplier
  • From:
  • To:
    Jiangsu Hengrui Pharmaceuticals Co., Ltd.
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service